Millennium Management’s Redhill Biopharma RDHL Stock Holding History

Millennium Management’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-529	Closed	-$74K	–	6771
2022 Q4	$74K	Sell	529 -95	-15%	-$41.1K	﹤0.01%	5671
2022 Q3	$314K	Buy	624 +251	+67%	+$219K	﹤0.01%	5323
2022 Q2	$324K	Buy	+373	New	+$512K	﹤0.01%	5301
2022 Q1	–	Sell	-175	Closed	-$452K	–	7381
2021 Q4	$452K	Buy	+175	New	+$700K	﹤0.01%	5141
2019 Q4	–	Sell	-17	Closed	-$118K	–	4563
2019 Q3	$118K	Sell	17 -49	-74%	-$357K	﹤0.01%	3935
2019 Q2	$427K	Sell	66 -33	-33%	-$254K	﹤0.01%	3337
2019 Q1	$819K	Sell	99 -203	-67%	-$1.61M	﹤0.01%	2983
2018 Q4	$1.67M	Buy	302 +124	+70%	+$950K	﹤0.01%	2298
2018 Q3	$1.57M	Buy	178 +152	+585%	+$1.24M	﹤0.01%	2607
2018 Q2	$222K	Buy	26 +16	+160%	+$102K	﹤0.01%	3527
2018 Q1	$53K	Buy	+10	New	+$57.6K	﹤0.01%	3538
2017 Q4	–	Sell	-20	Closed	-$212K	–	4026
2017 Q3	$212K	Buy	+20	New	+$178K	﹤0.01%	3213
2015 Q4	–	Sell	-14	Closed	-$178K	–	3715
2015 Q3	$178K	Buy	+14	New	+$207K	﹤0.01%	3152

Other funds holding RDHL

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Millennium Management's RDHL Position: Q1 2023 in Review

Millennium Management sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 529 shares — an estimated $74K sold.

Millennium Management first reported a position in RDHL in Q3 2015 and held it in 13 quarters. The position peaked at $1.67M in Q4 2018. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

Millennium Management reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 529 Redhill Biopharma shares in Q1 2023, an estimated $74K.
Millennium Management first reported a position in Redhill Biopharma in Q3 2015 and held it in 13 quarters.
Millennium Management's Redhill Biopharma position peaked at $1.67M in Q4 2018.
16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.